XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Apr. 30, 2023
Apr. 30, 2022
Operating activities    
Net income $ 35,608 $ 11,017
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 14,986 13,333
Deferred income taxes 9,200 4,624
Provision for doubtful accounts receivable 1,180 1,578
Net unrealized loss from marketable securities 3,151 19,705
Stock-based compensation 3,537 1,840
Other 2,114 3,486
Change in assets and liabilities:    
Trade accounts receivable (2,084) (8,461)
Disbursement prefunding, prepaid expenses, other current assets, and other assets (27,043) (20,504)
Trade accounts payable, accrued expenses, other current liabilities, and other liabilities (6,220) (2,566)
Customer deposits at IDT Financial Services Limited (Gibraltar-based bank) (2,570) (9,843)
Deferred revenue (3,160) (948)
Net cash provided by operating activities 28,699 13,261
Investing activities    
Capital expenditures (16,033) (13,794)
Purchase of convertible preferred stock in equity method investment (168) (1,051)
Payments for acquisitions, net of cash acquired (7,546)
Purchases of debt securities and equity investments (44,166) (11,277)
Proceeds from maturities and sales of debt securities and redemptions of equity investments 34,309 7,752
Net cash used in investing activities (26,058) (25,916)
Financing activities    
Distributions to noncontrolling interests (293) (359)
Proceeds from other liabilities 300 2,301
Repayment of other liabilities. (2,031) (1,319)
Proceeds from borrowings under revolving credit facility 2,383 2,566
Repayment of borrowings under revolving credit facility. (2,383) (2,566)
Proceeds from sale of redeemable equity in subsidiary 10,000
Proceeds from exercise of stock options 172 137
Repurchases of Class B common stock (7,845) (12,832)
Net cash used in financing activities (9,697) (2,072)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash and cash equivalents 2,537 (14,093)
Net decrease in cash, cash equivalents, and restricted cash and cash equivalents (4,519) (28,820)
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period 189,562 226,916
Cash, cash equivalents, and restricted cash and cash equivalents at end of period 185,043 198,096
Supplemental schedule of non-cash investing and financing activities    
Conversion of equity method investment’s secured promissory notes into convertible preferred stock 4,038
Stock issued to certain executive officers for bonus payments 615
Liabilities incurred for acquisitions 7,849
Shares of the Company’s Class B common stock issued for acquisition 1,000
Cashless exercise of stock options in exchange for shares of the Company’s Class B common stock $ 14,930